Will Pfizer Stock See Higher Levels After A 10% Rise In A Month?

The stock price of Pfizer has seen a rise of 10% over the last month, while it is down 6% YTD. The increase over the previous month can partly be attributed to Pfizer’s acquisition of Arena Pharmaceuticals for $6.7 billion. This is largely seen as a positive for Pfizer, given Arena’s robust drug...